Overview
My research focuses on the characterization of cognitive change with age. I am specifically interested in delineating the change between normal and pathologic changes associated with aging and developing therapies to delay decline.
My area of expertise is neurodegenerative diseases and dementia with an emphasis on Alzheimer's disease.
Keywords: Alzheimer's disease.
My area of expertise is neurodegenerative diseases and dementia with an emphasis on Alzheimer's disease.
Keywords: Alzheimer's disease.
Current Appointments & Affiliations
Professor of Neurology
·
2012 - Present
Neurology, Behavioral Neurology,
Neurology
Professor in Psychiatry and Behavioral Sciences
·
2021 - Present
Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences,
Psychiatry & Behavioral Sciences
Recent Publications
Beta amyloid PET scans for dementia diagnoses: Practice and research implications from CARE-IDEAS.
Journal Article J Am Geriatr Soc · October 2024 Beta amyloid PET scans are a minimally invasive biomarker that may inform Alzheimer's disease (AD) diagnosis. The Caregiver's Reactions and Experience (CARE) study, an IDEAS supplement, aimed to understand experiences of PET scan recipients and their care ... Full text Link to item CiteAssociation between results of an amyloid PET scan and healthcare utilization in individuals with cognitive impairment.
Journal Article J Am Geriatr Soc · March 2024 BACKGROUND: The Imaging Dementia Evidence for Amyloid Scanning (IDEAS) study reports that amyloid PET scans help providers diagnose and manage Alzheimer's disease and related dementias (ADRD). Using CARE-IDEAS, an IDEAS supplemental study, we examined the ... Full text Link to item CiteElevated Amyloid-β PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
Journal Article J Alzheimers Dis · 2024 BACKGROUND: Elevated amyloid-β (Aβ) on positron emission tomography (PET) scan is used to aid diagnosis of Alzheimer's disease (AD), but many prior studies have focused on patients with a typical AD phenotype such as amnestic mild cognitive impairment (MCI ... Full text Link to item CiteRecent Grants
Improving the lives of persons living with dementia and their families through person-centered measurement of home time
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2026Cognitive Training to Reduce Cognitive Impairment: The PACT Trial
ResearchPhysician · Awarded by University of South Florida · 2021 - 2026Open-Label Extension of Studies ATH-1017-0201 and ATH-1017-0202 in Subjects with Mild to Moderate Alzheimer¿s Disease
Clinical TrialPrincipal Investigator · Awarded by Athira Pharma, Inc. · 2021 - 2026View All Grants
Education, Training & Certifications
State University of New York, Brooklyn ·
1985
M.D.
University of Tennessee, Knoxville ·
1981
Ph.D.